Janssen Submits Marketing Authorisation Application to EMA Seeking Approval of Niraparib and Abiraterone Acetate Dual Action Tablet Plus Prednisone for the Treatment of Patients with HRR Gene-Mutated Metastatic Castration Resistant Prostate Cancer

The submission to the European Medicines Agency is based on results from the Phase 3 MAGNITUDE study evaluating niraparib in combination with abiraterone acetate plus prednisonefor the treatment of

Related Keywords

Japan ,United States ,American ,Laura Coughlan ,Gerhardt Attard ,Kiran Patel ,Mathai Mammen ,Zejula Sm ,Janssen Biotech Inc ,Tesaro Inc ,Janssen Research Development ,Janssen Pharmaceutical Companies ,Janssen Pharmaceutical Companies Of Johnson ,Janssen Cilag International ,International Agency For Research On Cancer ,European Union ,Clinical Development ,None Of The Janssen Pharmaceutical Companies ,World Health Organization ,European Commission ,Exchange Commission ,Companies Of Johnson ,European Medicines Agency ,Johnson ,Marketing Authorisation Application ,Professor Gerhardt ,Primary Study Investigator ,Clinician Scientist ,Team Leader ,University College London Cancer ,American Society ,Clinical Oncology Genitourinary Cancers Symposium ,Annual Meeting ,Vice President ,Solid Tumors ,Executive Vice President ,Janssen Biotech ,Metastatic Castration Resistant Prostate Cancer ,Pharmaceutical Companies ,Cardiovascular Metabolism ,Infectious Diseases Vaccines ,Research Development ,Concerning Forward Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Note Regarding Forward Looking ,Quarterly Reports ,Ataxia Telangiectasia ,Checkpoint Kinase ,Histone Deacetylase ,Last Accessed April ,Combination With Abiraterone Acetate ,Prednisone Versus Abiraterone Acetate ,Participants With Deleterious Germline ,Somatic Homologous Recombination Repair ,Prostate Cancer ,Prevalence Worldwide ,Del Pozo ,Prospective Cohort Study ,Janssen ,Ubmits ,Marketing ,Authorisation ,Application ,Seeking ,Approval ,Niraparib ,Abiraterone ,Acetate ,Ual ,Action ,Tablet ,Plus ,Prednisone ,Treatment ,Patients ,Gene ,Mutated ,Metastatic ,Castration ,